Vilnius-based pharmaceutical to produce cutting edge cancer treatment
Sicor Biotech/Teva Baltic, the largest pharmaceutical company in Lithuania, is preparing to begin production of a new active medicinal ingredient to be used in the treatment of cancer. The ingredient, XM21, will be produced in the company’s Vilnius facility from this autumn. As Giedrius Žunda, the director of the Vilnius unit explains, XM21 is already…